Rictor siRNA (h) from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images
Published Figures

Rictor siRNA (h)

Be the first to write a review!

Citations:

Figures:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
Rictor siRNA (h)

Description

Rictor siRNA (h)

Product Specs
ItemRictor siRNA (h)
CompanySanta Cruz Biotechnology, Inc.
Price $293.00Supplier Page View Company Product Page
Catalog Numbersc-61478
Gene NameRPTOR independent companion of MTOR, complex 2
Quantity10 µM
Specieshuman
NCBI Full Gene NameRPTOR independent companion of MTOR complex 2
NCBI Gene AliasesAVO3, PIA, hAVO3
TypesiRNA/dsRNA

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(21) DNA damage-induced S and G2/M cell cycle arrest requires mTORC2-dependent regulation of Chk1OncotargetJanuary 1, 2015Selvarajah J, Elia A, Carroll VA, Moumen A.

(22) 5-Aminoimidazole-4-carboxamide-1-β-4-ribofuranoside (AICAR) enhances the efficacy of rapamycin in human cancer cellsCell cycle (Georgetown, Tex.)January 1, 2015Mukhopadhyay S, Chatterjee A, Kogan D, Patel D, Foster DA.

(23) Tuberin-deficiency downregulates N-cadherin and upregulates vimentin in kidney tumor of TSC patientsOncotargetAugust 30, 2014Liang S, Salas T, Gencaslan E, Li B, Habib SL.

(24) Sustained overexpression of Redd1 leads to Akt activation involved in cell survivalCancer lettersAugust 19, 2013Jin HO, Hong SE, Kim JH, Choi HN, Kim K, An S, Choe TB, Hwang CS, Lee JH, Kim JI, et al.

(25) Perifosine sensitizes UVB-induced apoptosis in skin cells: new implication of skin cancer prevention?Cellular signallingSeptember 1, 2012Ji C, Yang YL, Yang Z, Tu Y, Cheng L, Chen B, Xia JP, Sun WL, Su ZL, He L, et al.

(26) Inhibition of mTOR kinase by AZD8055 can antagonize chemotherapy-induced cell death through autophagy induction and down-regulation of p62/sequestosome 1The Journal of biological chemistryNovember 18, 2011Huang S, Yang ZJ, Yu C, Sinicrope FA.

(27) Methylnaltrexone potentiates the anti-angiogenic effects of mTOR inhibitorsJournal of angiogenesis researchFebruary 19, 2010Singleton PA, Mambetsariev N, Lennon FE, Mathew B, Siegler JH, Moreno-Vinasco L, Salgia R, Moss J, Garcia JG.

Be the First to Write a Review!